SM Lido 10.56% Professional Numbing Cream – High-Potency Lidocaine Formula (30g Jar)

Both products use the same 10.56% lidocaine HCl active ingredient, but each is formulated and tested as its own batch with its own emulsion base – this 30g jar uses a water-in-oil emulsion with methylparaben preservative, targeted at pH 6.5–7.5 and rated for full epidermal penetration in 7–10 minutes with 60–90 minutes of analgesia. The 500g SM Cream is a separate formulation targeted at pH 6.2–6.8 with a 10–12 minute onset and 90±15 minute duration. Small formulation differences like preservative system and emulsion type can shift the optimal pH range and absorption timeline slightly, even when the headline active ingredient percentage is identical. If your protocol depends on a specific onset/duration window, refer to the specification table for the exact jar size you’re using.

This is a systemic safety ceiling based on the patient’s body weight, expressed as milligrams of lidocaine per kilogram. To estimate it: multiply the patient’s weight in kilograms by 4mg, then compare that figure to the amount of lidocaine actually applied (the cream is 105.6mg of lidocaine per gram, so a 2ml/~2g standard application contains roughly 211mg of lidocaine). For most adult patients at typical body weights, a single 2ml standard-session application falls well within this limit, but practitioners treating larger areas, smaller patients, or applying cream more than once in a session should calculate cumulative lidocaine dose against the patient’s weight-based maximum.

The 0.03% figure describes how rarely an allergic reaction has occurred in reported use – it is low, but not zero, which is why basic emergency preparedness is part of the safety guidance regardless of setting size. “Resuscitation equipment must be accessible” reflects standard precaution language for amide-anesthetic products generally, acknowledging that allergic and rare systemic reactions, while uncommon, require a plan. In practice, this means any setting using this product – clinic or home – should have a basic emergency response plan (knowing local emergency contacts, recognizing reaction symptoms, and not using the product on patients with known anesthetic allergies) rather than assuming a rare event cannot happen.

Areas of the body differ in how thick the skin is and how much blood flow (vascularity) is near the surface. Thinner skin and areas with richer blood supply – such as the lips, eyelids, or inner forearm – tend to absorb topical anesthetics faster, which can push the effective onset toward the quicker end of the 7–10 minute range. Thicker-skinned or less vascular areas – such as the soles of the feet or areas with calloused skin – may take closer to the slower end, or slightly longer. The ±12–18% variance is a way of communicating that the 7–10 minute and 60–90 minute figures are averages, and individual sites and patients may fall somewhat outside that range.

The 2ml “standard session” figure is a reference dose for a typical localized treatment area at the 0.5g/cm² application rate. A 30g jar (roughly 30ml of cream, density-dependent) at a 2ml-per-session rate works out to somewhere in the range of a dozen or more standard sessions, depending on the actual treatment area size each time – smaller spot treatments will use less than 2ml and stretch the jar further, while larger areas will use more per session and reduce the total session count.